Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Conditions
- Metastatic Castration-Resistant Prostate Carcinoma
- Metastatic Prostate Adenocarcinoma
- Stage IVB Prostate Cancer AJCC v8
Interventions
- DRUG: Lutetium Lu 177 Vipivotide Tetraxetan
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Patient Monitoring
- PROCEDURE: Computed Tomography
- PROCEDURE: Bone Scan
- PROCEDURE: PSMA PET Scan
- PROCEDURE: MRI
- OTHER: Questionnaire Administration
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators